Phenotypic activation of CD8 + T cells of the discovery and validation cohort was measured using a CD8 T cell specific ssGSEA pathway contrasting gene expression of naive and cancer killing effector cells (GSE22886: Naive CD8 T cell vs NK cell up pathway). This evidence concerns the gene CD8A and cancer.